- United States
- /
- Tobacco
- /
- NYSE:MO
Altria (MO): Assessing Valuation After a Quiet 11% Gain Powered by Steady Income Returns
Reviewed by Simply Wall St
Altria Group (MO) has quietly ground higher this year, up about 11% over the past year and roughly flat over the past month, as investors reassess its income and value appeal.
See our latest analysis for Altria Group.
With the share price now around $58.11, Altria’s modest year to date share price gain alongside a solid three and five year total shareholder return suggests steady income driven momentum rather than a fast growth story, as investors stay comfortable with its risk profile.
If you are weighing up income names like Altria, it might also be worth exploring other steady compounders via fast growing stocks with high insider ownership for fresh ideas beyond the traditional dividend space.
Yet, with modest top-line growth, solid cash generation, and the shares trading at a sizeable discount to some intrinsic value estimates, investors must decide whether Altria is quietly undervalued or if the market is already pricing in its future growth.
Most Popular Narrative Narrative: 9% Undervalued
With Altria’s last close at $58.11 against a most popular narrative fair value of $63.83, the story leans toward a discounted income heavyweight built on durable cash flows rather than rapid expansion.
The analysts have a consensus price target of $58.538 for Altria Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $73.0, and the most bearish reporting a price target of just $49.0.
Curious how a business with shrinking margins, barely growing revenue, and modest earnings expectations can still justify a higher future multiple and richer fair value? The narrative leans heavily on slow but steady profit power, disciplined buybacks and a carefully chosen discount rate to close the gap between today’s price and tomorrow’s implied upside. Want to see exactly which earnings path and valuation multiple this storyline is betting on, and how those assumptions stack up over the next few years?
Result: Fair Value of $63.83 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, stable earnings are not guaranteed, as tougher e vapor regulation or faster illicit and synthetic nicotine competition could quickly erode margins and market share.
Find out about the key risks to this Altria Group narrative.
Build Your Own Altria Group Narrative
If you see the story differently or prefer digging through the numbers yourself, you can build a fully custom view in just a few minutes. Do it your way
A great starting point for your Altria Group research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
Ready for more high conviction ideas?
If you only stop at Altria, you could miss other powerful opportunities shaping the market right now, so give yourself options and broaden your watchlist intelligently.
- Capture potential mispricings by scanning these 902 undervalued stocks based on cash flows that the market may be overlooking despite strong underlying cash flows.
- Ride structural growth trends by targeting these 30 healthcare AI stocks using data driven innovation to transform patient outcomes and profitability.
- Target reliable income prospects by reviewing these 15 dividend stocks with yields > 3% that aim to combine solid yields with sustainable payout profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:MO
Altria Group
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
6 star dividend payer and undervalued.
Similar Companies
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives
This one is all about the tax benefits
Estimated Share Price is $79.54 using the Buffett Value Calculation
Halyk Bank of Kazakhstan will see revenue grow 11% as their future PE reaches 3.2x soon
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
